AI model spots prostate cancer with fewer needles
Diagnosis
Completed
This study tested a new AI system that combines blood tests (cfDNA) and MRI scans to more accurately detect prostate cancer. The goal was to help men with borderline PSA levels avoid unnecessary biopsies. Over 1,600 men participated, including those with healthy prostates, enlarg…
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC